Company intelligence / Profile preview

Cambridge Isotope Laboratories

Tewksbury, Massachusetts, United Statesisotope.com ↗

Ownership: Private
Employees: ~700
Development stage: Commercial

Overview

CIL supplies over 15,000 stable isotope-labeled products used globally in life sciences research, diagnostics, environmental analysis, drug development support, and industrial applications. The company does not conduct clinical trials or have a therapeutic pipeline.

Modalities: Small moleculeProteinDiagnostic reagentNucleic acidPeptides
Industry: Chemicals & Materials

Partnerships

Not specifically disclosed; serves as supplier to pharma/biotech/academic/government sectors worldwide.

Beyond the preview

Go deeper on Cambridge Isotope Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cambridge Isotope Laboratories.